StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer's (PFE) Biosimilar to Amgen's (AMGN) Neupogen Approved by FDA - Bloomberg
July 20, 2018 3:10 PM
Pfizer's (NYSE: PFE) Biosimilar ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Next Articles
Pfizer (PFE), GlaxoSmithKline Company ViiV Healthcare Announces SWORD 100-Week Data for Juluca (dolutegravir/rilpivirine) at AIDS 2018
July 24, 2018 5:54 AM
Pfizer (PFE), GlaxoSmithKline Company ViiV Healthcare Highlights Phase III Data at AIDS 2018
July 24, 2018 5:49 AM